Clinical trial
Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography: a Randomized Controlled Trial
NCT04505657 is registered in ClinicalTrials.gov with Aswan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography: a Randomized Controlled Trial
- Lead sponsor
- Aswan University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2020
- Completion date
- September 27, 2021
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
iucd complication